AHFS January 2024 Update

This update contains 9 new monographs, 31 revised monographs, and 2 new MedWatch alerts.

New monographs: Bimekizumab-bkzx; Etrasimod Arginine; Gepirone Hydrochloride; Mirikizumab-mrkz; Nedosiran Sodium; Phentolamine Mesylate; Tenapanor Hydrochloride (Phosphate-removing Agent); Toripalimab-tpzi; Vamorolone.

Revised monographs: Afamelanotide Acetate; AHFS Drug Information® Users Guide; Berotralstat Dihydrochloride; Dabrafenib Mesylate; Editorial Staff; Epoetin Alfa; Finerenone; Ibalizumab-uiyk; Icatibant Acetate; Ixekizumab; Mercaptopurine; Nirsevimab-alip; Notices; Ozanimod Hydrochloride; Pegfilgrastim; Preface; Rifamycin Sodium; Sargramostim; Spesolimab-sbzo; SUFentanil Citrate; Sutimlimab-jome; Tebentafusp-tebn; Tirzepatide; Tremelimumab-actl; Trientine; Trifarotene; Trilaciclib Dihydrochloride; Ustekinumab; Vedolizumab; Viloxazine Hydrochloride; Zuranolone.

New MedWatch alerts on the following monographs: COVID-19 Vaccine, mRNA (Moderna); Insulin Detemir.